EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis

Chaozhi Bu, Mengyuan Hu, Yinglin Su, Fuqiang Yuan, Yiting Zhang, Jing Xia, Zhenyu Jia, Le Zhang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Chaozhi Bu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi, China. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Intestinal Mucosa, Inflammation, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Wuxi health Commission, Top medical expert team of Wuxi Taihu Talent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal dysbiosis is believed to play a role in the development of necrotizing enterocolitis (NEC). The efficacy of JNK‐inhibitory peptide (CPJIP) in treating NEC was assessed. Treatment with CPJIP led to a notable reduction in p‐JNK expression in IEC‐6 cells and NEC mice. Following LPS stimulation, the expression of RNA and protein of claudin‐1, claudin‐3, claudin‐4 and occludin was significantly decreased, with this decrease being reversed by CPJIP administration, except for claudin‐3, which remained consistent in NEC mice. Moreover, the expression levels of the inflammatory factors TNF‐α, IL‐1β and IL‐6 were markedly elevated, a phenomenon that was effectively mitigated by the addition of CPJIP in both IEC‐6 cells and NEC mice. CPJIP administration resulted in improved survival rates, ameliorated microscopic intestinal mucosal injury, and increased the total length of the intestines and colon in NEC mice. Additionally, CPJIP treatment led to a reduction in serum concentrations of FD‐4, D‐lactate and DAO. Furthermore, our results revealed that CPJIP effectively inhibited intestinal cell apoptosis and promoted cell proliferation in the intestine. This study represents the first documentation of CPJIP's ability to enhance the expression of tight junction components, suppress inflammatory responses, and rescue intestinal cell fate by inhibiting JNK activation, ultimately mitigating intestinal severity. These findings suggest that CPJIP has the potential to serve as a promising candidate for the treatment of NEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterocolitis, NecrotizingIntestinal MucosaInflammationApoptosisAnimalsMicePeptidesDisease Models, AnimalCell ProliferationMice, Inbred C57BLCell LineRatsJNK Mitogen-Activated Protein KinasesLipopolysaccharidesIntestinal Barrier Function

Stichwörter der Autor:innen

CPJIPJNKintestinal barriernecrotizing enterocolitistight junction

Substanzen

PeptidesJNK Mitogen-Activated Protein KinasesLipopolysaccharides

Autor:innen und Institutionen

  • Department of Neonatology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Wuxi, China.
  • State Key Laboratory of Reproductive Medicine, Research Institute for Reproductive Health and Genetic Diseases, Wuxi Maternity and Child Health Care Hospital, Women's Hospital of Jiangnan University, Jiangnan University…
  • Department of Neonatology, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
  • Department of Gastroenterology and Digestive Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

ORCID-Profile: Le Zhang

Förderung

  • National Natural Science Foundation of China
  • Project of Wuxi health Commission
  • Top medical expert team of Wuxi Taihu Talent Program
  • Medical Key Discipline Program of Wuxi Health Commission
  • Wuxi Science and Technology Development Fund
  • Top Talent Support Program for young and middle-aged people of Wuxi Health Committee
  • the 333 project of Jiangsu Province in 2022

Zitieren

APA

Bu, C., Hu, M., Su, Y., Yuan, F., Zhang, Y., Xia, J., Jia, Z., & Zhang, L. (2024). Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18534

Vancouver

Bu C, Hu M, Su Y, Yuan F, Zhang Y, Xia J, et al. Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18534

BibTeX
@article{Bu2024,
  author = {Bu, Chaozhi and Hu, Mengyuan and Su, Yinglin and Yuan, Fuqiang and Zhang, Yiting and Xia, Jing and Jia, Zhenyu and Zhang, Le},
  title = {Cell‐permeable JNK ‐inhibitory peptide regulates intestinal barrier function and inflammation to ameliorate necrotizing enterocolitis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18534}
}
Kostenlos starten →